Sunshine Biopharma Inc (SBFM)
0.93
+0.04
(+4.49%)
USD |
NASDAQ |
May 17, 16:00
0.92
-0.01
(-1.08%)
After-Hours: 20:00
Sunshine Biopharma Revenue (TTM): 24.09M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 24.09M |
| September 30, 2023 | 20.35M |
| June 30, 2023 | 14.53M |
| March 31, 2023 | 9.117M |
| December 31, 2022 | 4.346M |
| September 30, 2022 | 0.4909M |
| June 30, 2022 | 0.4084M |
| March 31, 2022 | 0.311M |
| December 31, 2021 | 0.2284M |
| Date | Value |
|---|---|
| September 30, 2021 | 0.1713M |
| June 30, 2021 | 0.1381M |
| March 31, 2021 | 0.1004M |
| December 31, 2020 | 0.0714M |
| September 30, 2020 | 0.054M |
| June 30, 2020 | 0.0441M |
| March 31, 2020 | 0.032M |
| December 31, 2019 | 0.0211M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
0.0211M
Minimum
Dec 2019
24.09M
Maximum
Dec 2023
4.383M
Average
0.2284M
Median
Dec 2021
Revenue (TTM) Benchmarks
| Lexaria Bioscience Corp | 0.386M |
| Acasti Pharma Inc | -- |
| Aurinia Pharmaceuticals Inc | 175.51M |
| Edesa Biotech Inc | -- |
| Xenon Pharmaceuticals Inc | -- |